Top Cardiology Research Papers

Overall: This rigorous, large trial shows that atorvastatin moderately reduces major cardiovascular events in healthy older adults without extending disability-free survival, offering directly actionable evidence for US preventive care.

Overall: A large randomized trial found that physiology-guided complete revascularization produced a meaningful reduction in clinical events and fewer major safety events than conventional angiographic guidance.

Overall: This randomized multicenter trial found a large improvement in arrhythmia-free survival and quality of life without greater serious harm, supporting a potentially practice-changing but specialized ablation strategy.

Overall: A large, precise randomized-trial meta-analysis supports blood-pressure lowering to prevent major cardiovascular events throughout CKD, but absent absolute effects and harms limit conclusions about net benefit.

Overall: This randomized trial reports a large, precise improvement in major patient outcomes, balanced against procedural adverse events and the need for specialized structural-heart resources.

Overall: A large and precise randomized-trial meta-analysis demonstrates early, modest reductions in major cardiovascular events from blood-pressure lowering, with high primary-care relevance but limited novelty and no reported harms.

Overall: This well-conducted randomized trial found a clinically meaningful reduction in repeat limb procedures or major amputation without an evident one-year safety penalty, supporting potential adoption during infrainguinal angioplasty.

Overall: A large randomized trial analysis shows clinically meaningful reductions in first and recurrent cardiovascular events, though absent safety reporting and the practical burdens of evolocumab temper the net impact.

Overall: This large, rigorous trial found a modest but clinically meaningful reduction in recurrent ischemic stroke without a demonstrated increase in major bleeding, making the findings likely to influence secondary prevention practice.

Overall: This multicenter randomized trial found a clinically substantial reduction in short-term death, recurrent embolism, or decompensation without higher aggregate bleeding, but open-label assessment, few events, two intracranial hemorrhages, and the need for specialized catheter-based care temper the result.